Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Net Margin (2023 - 2025)

Historic Net Margin for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to 2623.53%.

  • CG Oncology's Net Margin rose 448299600.0% to 2623.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 6963.43%, marking a year-over-year increase of 45466600.0%. This contributed to the annual value of 7729.5% for FY2024, which is 255048100.0% up from last year.
  • CG Oncology's Net Margin amounted to 2623.53% in Q3 2025, which was up 448299600.0% from 66263.46% recorded in Q1 2025.
  • In the past 5 years, CG Oncology's Net Margin ranged from a high of 2623.53% in Q3 2025 and a low of 2249000.0% during Q4 2023
  • For the 3-year period, CG Oncology's Net Margin averaged around 288170.62%, with its median value being 17028.83% (2024).
  • In the last 5 years, CG Oncology's Net Margin skyrocketed by 2000000000bps in 2024 and then tumbled by -630627100bps in 2025.
  • Over the past 3 years, CG Oncology's Net Margin (Quarter) stood at 2249000.0% in 2023, then skyrocketed by 100bps to 6973.25% in 2024, then soared by 62bps to 2623.53% in 2025.
  • Its last three reported values are 2623.53% in Q3 2025, 66263.46% for Q1 2025, and 6973.25% during Q4 2024.